News Search Results
Jun 09, 2026, 09:00 ET 10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
advance human health.The terms of the transaction were not disclosed. 10x Genomics believes the transaction will not meaningfully impact its near-term financial outlook.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery
More news about: 10x Genomics, Inc.
May 08, 2026, 11:44 ET Advaita Bio představuje iSCanGuide™: Integrovanou analýzu jednobuněčné a prostorové transkriptomiky využívající infrastrukturu s GPU akcelerací
datům v každé fázi.Analýza prostorové transkriptomiky: Mapujte genovou expresi v jejím nativním tkáňovém kontextu s plnou podporou 10x Genomics Visium (Standard/HD) a Xenium. Vizualizujte prostorové rozložení buněk a identifikujte prostorově variabilní geny – to vše ve stejném prostředí,
More news about: Advaita Bio
May 07, 2026, 16:05 ET 10x Genomics Reports First Quarter 2026 Financial Results
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
May 07, 2026, 12:08 ET Advaita Bio wprowadza iSCanGuide™: ujednoliconą analizę transkryptomiki pojedynczych komórek i przestrzennej opartą na infrastrukturze akcelerowanej przez GPU
- Analiza transkryptomiki przestrzennej: mapowanie ekspresji genów w ich naturalnym kontekście tkankowym z pełną obsługą platform 10x Genomics Visium (Standard/HD) oraz Xenium. Wizualizacja przestrzennych rozmieszczeń komórek i identyfikacja genów zmiennych przestrzennie - wszystko w tym
More news about: Advaita Bio
May 07, 2026, 12:04 ET Advaita Bio spúšťa iSCanGuide™: platformu pre analýzu jednobunkových a priestorových transkriptomických dát s akceleráciou GPU
každej fáze.Analýza priestorovej transkriptomiky: mapuje génovú expresiu v jej prirodzenom tkanivovom kontexte s plnou podporou pre 10x Genomics Visium (Standard/HD) a Xenium. Vizualizuje priestorové rozloženie buniek a identifikuje priestorovo variabilné gény – to všetko v rovnakom prostredí
More news about: Advaita Bio
May 07, 2026, 11:52 ET Advaita Bio lance iSCanGuide™ : analyse unifiée de la transcriptomique unicellulaire et spatiale, reposant sur une infrastructure optimisée par GPU
transcriptomique spatiale : cartographie de l'expression des gènes dans leur contexte tissulaire d'origine grâce à la prise en charge complète de 10x Genomics Visium (Standard/HD) et Xenium. Visualisez la distribution spatiale de cellules et identifiez les gènes à variation spatiale, le tout dans le même
More news about: Advaita Bio
May 07, 2026, 10:55 ET Advaita Bio lanza iSCanGuide™
etapa.Análisis de transcriptómica espacial: Mapea la expresión génica en su contexto tisular nativo con compatibilidad total con 10x Genomics Visium (Standard/HD) y Xenium. Visualiza distribuciones celulares espaciales e identifica genes espacialmente variables, todo dentro del mismo entorno
More news about: Advaita Bio
May 07, 2026, 10:54 ET Advaita Bio bringt iSCanGuide™ auf den Markt: Vereinheitlichte Analyse für Einzelzell-Transkriptomik und räumliche Transkriptomik, gestützt auf GPU-beschleunigte Infrastruktur
anpassen.Analyse der räumlichen Transkriptomik: Erfasst die Genexpression in ihrem nativen Gewebekontext mit vollständiger Unterstützung für 10x Genomics Visium (Standard/HD) und Xenium. Räumliche Zellverteilungen lassen sich visualisieren und räumlich variable Gene identifizieren, und zwar innerhalb
More news about: Advaita Bio
May 07, 2026, 07:45 ET Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
your data at every stage.Spatial Transcriptomics Analysis: Map gene expression in its native tissue context with full support for 10x Genomics Visium (Standard/HD) and Xenium. Visualize spatial cell distributions and identify spatially variable genes — all within the same environment used
More news about: Advaita Bio
May 07, 2026, 07:45 ET Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
your data at every stage.Spatial Transcriptomics Analysis: Map gene expression in its native tissue context with full support for 10x Genomics Visium (Standard/HD) and Xenium. Visualize spatial cell distributions and identify spatially variable genes — all within the same environment used
More news about: Advaita Bio
Apr 29, 2026, 16:05 ET 10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Apr 29, 2026, 09:00 ET The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
VPTDF), Senseonics (NASDAQ: SENS), TransMedics Group (NASDAQ: TMDX), WELL Health Technologies (TSX: WELL) (OTCQX: WHTCF), and 10x Genomics (NASDAQ: TXG).
More news about: Equity Insider
Apr 29, 2026, 05:00 ET Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology
Columbia University, University of Washington, ETH Zurich, and the Genome Institute of Singapore, in collaboration with industry partners 10x Genomics and Ultima Genomics."Biohub's investments in efforts like the Billion Cells Project and CELLxGENE are generating datasets that are already
More news about: Biohub
Apr 18, 2026, 22:00 ET 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Apr 15, 2026, 16:05 ET 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Mar 25, 2026, 07:00 ET Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
www.bioptimus.comMedia Contact: [email protected] 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: Bioptimus
Mar 25, 2026, 07:00 ET Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
www.bioptimus.comMedia Contact: [email protected] 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: Bioptimus
Mar 17, 2026, 08:00 ET PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
- Dataset of 8 million brain-wide cells, generated and analyzed in collaboration with NVIDIA, Allen Institute for Brain Science and 10x Genomics, establishes the largest causal map of gene function in living tissue, showcasing the power of PerturbAI's scalable discovery
More news about: PerturbAI
Feb 19, 2026, 16:05 ET 10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Feb 12, 2026, 22:20 ET Omics Empower 香港實驗室正式推出 Xenium™ 原位空間轉錄組服務
降解風險並維持細胞活力，從而支持高品質單細胞數據的生成，同時提升專案溝通與執行效率。Xenium™ 由 10x Genomics 開發，可在保留組織空間結構的前提下，對 RNA 分子進行原位定位與定量分析，實現單細胞及亞細胞層級解析度。該技術廣泛應用於腫瘤微環境研究、神經科學、免疫學及轉譯醫學等領域，有助於研究人員解析細胞在原位環境中的分子特徵與空間組織關係。據公開資料顯示，Omics Empower 香港實驗室為全港第二家運行 Xenium 平台的實驗室，進一步擴展本地高端空間轉錄組技術的應用能力。除 Xenium™ 外，香港實驗室亦支援 10x Genomics Visium 全轉錄組空間分析，以及由 BGI 集團開發的
More news about: Omics Empower
Feb 12, 2026, 16:05 ET 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Feb 04, 2026, 09:00 ET PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Jan 22, 2026, 16:05 ET 10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jan 22, 2026, 10:30 ET Next-Generation Sequencing Market worth $29.53 billion by 2030 | MarketsandMarkets™
Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Merck KGaA (Germany), BD (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co. Ltd.
More news about: MarketsandMarkets
Jan 12, 2026, 09:11 ET 10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.